These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28783500)

  • 1. Treatment with PTEN-Long protein inhibits hepatitis C virus replication.
    Wu Q; Li Z; Liu Q
    Virology; 2017 Nov; 511():1-8. PubMed ID: 28783500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of PTEN - HCV core interaction in hepatitis C virus replication.
    Wu Q; Li Z; Mellor P; Zhou Y; Anderson DH; Liu Q
    Sci Rep; 2017 Jun; 7(1):3695. PubMed ID: 28623358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN.
    Wu Q; Li Z; Liu Q
    Virology; 2018 Jul; 520():94-102. PubMed ID: 29803738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets.
    Clément S; Peyrou M; Sanchez-Pareja A; Bourgoin L; Ramadori P; Suter D; Vinciguerra M; Guilloux K; Pascarella S; Rubbia-Brandt L; Negro F; Foti M
    Hepatology; 2011 Jul; 54(1):38-49. PubMed ID: 21465511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism.
    Peyrou M; Clément S; Maier C; Bourgoin L; Branche E; Conzelmann S; Kaddai V; Foti M; Negro F
    J Hepatol; 2013 Sep; 59(3):420-6. PubMed ID: 23623999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein.
    Clément S; Sobolewski C; Gomes D; Rojas A; Goossens N; Conzelmann S; Calo N; Negro F; Foti M
    Liver Int; 2019 Jul; 39(7):1226-1236. PubMed ID: 30938910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner.
    Gao TT; Qin ZL; Ren H; Zhao P; Qi ZT
    Virol J; 2015 Feb; 12():12. PubMed ID: 25645159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
    Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
    J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication.
    Maehama T; Fukasawa M; Date T; Wakita T; Hanada K
    Biochem Biophys Res Commun; 2013 Oct; 440(1):150-6. PubMed ID: 24055031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A.
    Shier MK; El-Wetidy MS; Ali HH; Al-Qattan MM
    Saudi J Gastroenterol; 2016; 22(3):240-8. PubMed ID: 27184644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of PTEN by HCV core protein through activating nuclear factor-κB.
    Zhang Y; Li RQ; Feng XD; Zhang YH; Wang L
    Int J Clin Exp Pathol; 2014; 7(11):7351-9. PubMed ID: 25550771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
    Del Campo JA; García-Valdecasas M; Gil-Gómez A; Rojas Á; Gallego P; Ampuero J; Gallego-Durán R; Pastor H; Grande L; Padillo FJ; Muntané J; Romero-Gómez M
    PLoS One; 2018; 13(1):e0191805. PubMed ID: 29385181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue.
    Harouaka D; Engle RE; Wollenberg K; Diaz G; Tice AB; Zamboni F; Govindarajan S; Alter H; Kleiner DE; Farci P
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1375-80. PubMed ID: 26787866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of presenilin inhibitor LY411575 on maturation of hepatitis C virus core protein, production of the viral particle and expression of host proteins involved in pathogenicity.
    Otoguro T; Tanaka T; Kasai H; Yamashita A; Moriishi K
    Microbiol Immunol; 2016 Nov; 60(11):740-753. PubMed ID: 27797115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
    Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
    Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells.
    Pan XB; Qu XW; Jiang D; Zhao XL; Han JC; Wei L
    Antiviral Res; 2013 Apr; 98(1):54-60. PubMed ID: 23422647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
    De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
    J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner.
    Jia B; Yu D; Yu G; Cheng Y; Wang Y; Yi X; Li X; Wang Y
    Biomed Pharmacother; 2018 Jul; 103():746-754. PubMed ID: 29684853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.